PlainPharmaWatch

CMS Open Payments · Program Year 2024

Immunitybio, Inc.

Immunitybio, Inc. reported $67,816.03 across General Payments, Research, and Ownership to 1,612 physicians and teaching hospitals across 1,612 transactions.

$67.8K Below-median payer
All-tracks total
1,612 Top quartile volume
Transactions
1,612 Top quartile reach
Recipients
#1276
of 1,925 companies

Immunitybio, Inc. reported $67,816.03 across all CMS Open Payments tracks (General + Research + Ownership) to 1,612 physicians and teaching hospitals in Program Year 2024 - ranking #1276 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $67,816.03, averaging $42.07 per recipient.

Immunitybio, Inc.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

23/100

Total payments

F

11/100

Transaction volume

F

22/100

Physician reach

F

22/100

Payment type diversity

F

37/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer immunitybio-inc Immunitybio, Inc.

$67.8K · #1276/1,925 · 0.0% industry · PY2024

  • TOT $67.8K
  • RANK #1276
  • SHARE 0.0%
  • TXN 1,612
  • RCP 1,612
  • CAT 3
  • GEN $67.8K
  • TOP1 5.7%
  • PY 2024

Nearest volume peer: Shimadzu Precision Instruments, Inc. ($67.9K)

RedHill Biopharma Inc.$68.8KShimadzu Precision Instrumen…$67.9KImmunitybio, Inc. (this)$67.8KMIM Software Inc.$67.1KIcometrix NV$67.0K
All-tracks payment totals near Immunitybio, Inc. (CMS Open Payments PY2024)

Immunitybio, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Immunitybio, Inc.

CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Immunitybio, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.

The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $44.0K, accounting for 64.9% of this company's General Payments and 1,599 transactions.

General Payment Breakdown by Type

Immunitybio, Inc. made 3 types of general payments. "Food and Beverage" is the largest category at $44.0K, 64.9% of General Payments.

How Immunitybio, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Food and Beverage$44.0K2. Honoraria$17.6K3. Consulting Fee$6.2K
Payment Type Amount Transactions
Food and Beverage $44.0K 1,599
Honoraria $17.6K 11
Consulting Fee $6.2K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $13,187.01 (19.4%) of $67,816.03 in this company's General Payments records across 1,282 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Immunitybio, Inc.

The five named recipients with the highest reported General Payments from this company

Jason Matthew Hafron$3.9KGary Steinberg$2.4KPeter O Donnell$2.4KJoshua Meeks$2.4KArpeet Satish Shah$2.1K
  1. 1

    Jason Matthew Hafron

    $3,864.40 across 5 reported transactions

  2. 2

    Gary Steinberg

    $2,400.00 across 1 reported transactions

  3. 3

    Peter O Donnell

    $2,400.00 across 1 reported transactions

  4. 4

    Joshua Meeks

    $2,400.00 across 1 reported transactions

  5. 5

    Arpeet Satish Shah

    $2,122.61 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Immunitybio, Inc. ranks #1276 of 1,925 by total payments (bottom 34% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,654 of 1,838 by HHI (bottom 10% least concentrated), a wider distribution than most similarly sized payers.

02.65.37.910.5118.6120.8123125.2127.4Total payments ($M)Concentration (HHI, 0-10,000)
Immunitybio, Inc. (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Immunitybio, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Immunitybio, Inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Immunitybio, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Immunitybio, Inc. ranks #1276 of 1,925 by all-tracks total payments, led by "Food and Beverage".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Immunitybio, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.